NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · Real-Time Price · USD

1.240

-0.150 (-10.79%)

At close: Mar 9, 2026, 4:00 PM EDT

1.201

-0.039 (-3.14%)

After-hours: Mar 9, 2026, 5:54 PM EDT

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $32.39 million as of March 9, 2026. Its market cap has increased by 944.99% in one year.

Market Cap

32.39M

Enterprise Value

28.57M

1-Year Change

944.99%

Ranking

#4811

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $32.39M, a decrease of -57.65%. That is a compound annual growth rate of -4.57%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	35.00M	-95.08%
Dec 31, 2025	710.70M	24,406.90%
Dec 31, 2024	2.90M	123.08%
Dec 29, 2023	1.30M	-63.89%
Dec 30, 2022	3.60M	-78.70%
Dec 31, 2021	16.90M	-41.92%
Dec 31, 2020	29.10M	62.57%
Dec 31, 2019	17.90M	35.61%
Dec 31, 2018	13.20M	-77.70%
Dec 29, 2017	59.20M	18.64%
Dec 30, 2016	49.90M	612.86%
Dec 31, 2015	7.00M	-78.46%
Dec 31, 2014	32.50M	-32.85%
Dec 31, 2013	48.40M	43.62%
Dec 31, 2012	33.70M	-11.32%
Dec 30, 2011	38.00M	-1.55%
Dec 31, 2010	38.60M	-19.42%
Dec 31, 2009	47.90M	118.72%
Dec 31, 2008	21.90M	-72.63%
Dec 31, 2007	80.00M	4.58%

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jasper Therapeutics	38.62M
CervoMed	38.03M
Sensei Biotherapeutics	37.96M
Actinium Pharmaceuticals	37.44M
Atara Biotherapeutics	37.28M
Lisata Therapeutics	36.87M
Tvardi Therapeutics	36.87M
PDS Biotechnology	36.82M

Market Cap Rankings